These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 25857561)
21. [Cross-resistance between rifampicin and rifabutin among multi-drug resistant Mycobacterium tuberculosis strains]. Chikamatsu K; Mizuno K; Yamada H; Mitarai S Kekkaku; 2009 Sep; 84(9):631-3. PubMed ID: 19860266 [TBL] [Abstract][Full Text] [Related]
22. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Barnard M; Albert H; Coetzee G; O'Brien R; Bosman ME Am J Respir Crit Care Med; 2008 Apr; 177(7):787-92. PubMed ID: 18202343 [TBL] [Abstract][Full Text] [Related]
23. Drug-resistant tuberculosis in Cuba. Results of the three global projects. Montoro E; Lemus D; Echemendía M; Armas L; González-Ochoa E; Llanes MJ; Valdivia JA Tuberculosis (Edinb); 2006; 86(3-4):319-23. PubMed ID: 16569512 [TBL] [Abstract][Full Text] [Related]
24. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis. Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154 [TBL] [Abstract][Full Text] [Related]
25. Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa. Streicher EM; Müller B; Chihota V; Mlambo C; Tait M; Pillay M; Trollip A; Hoek KG; Sirgel FA; Gey van Pittius NC; van Helden PD; Victor TC; Warren RM Infect Genet Evol; 2012 Jun; 12(4):686-94. PubMed ID: 21839855 [TBL] [Abstract][Full Text] [Related]
26. Resistance patterns of multidrug-resistant tuberculosis in Western Province, Papua New Guinea. Simpson G; Coulter C; Weston J; Knight T; Carter R; Vincent S; Robertus L; Konstantinos A Int J Tuberc Lung Dis; 2011 Apr; 15(4):551-2. PubMed ID: 21396218 [TBL] [Abstract][Full Text] [Related]
27. Changing patterns and trends of multidrug-resistant tuberculosis at referral centre in Northern India: a 4-year experience. Maurya AK; Singh AK; Kumar M; Umrao J; Kant S; Nag VL; Kushwaha RA; Dhole TN Indian J Med Microbiol; 2013; 31(1):40-6. PubMed ID: 23508428 [TBL] [Abstract][Full Text] [Related]
28. Integrated detection of multi- and extensively drug-resistant tuberculosis using the nitrate reductase assay. Ramos E; Fissette K; de Rijk P; Palomino JC; Martin A Int J Tuberc Lung Dis; 2012 Jan; 16(1):110-3. PubMed ID: 22236855 [TBL] [Abstract][Full Text] [Related]
29. Primary drug resistance among pulmonary treatment-naïve tuberculosis patients in Amazonas State, Brazil. da Silva Garrido M; Ramasawmy R; Perez-Porcuna TM; Zaranza E; Chrusciak Talhari A; Martinez-Espinosa FE; Bührer-Sékula S Int J Tuberc Lung Dis; 2014 May; 18(5):559-63. PubMed ID: 24903793 [TBL] [Abstract][Full Text] [Related]
30. Concomitant increases in spectrum and level of drug resistance in Mycobacterium tuberculosis isolates. Sun Z; Zhang J; Song H; Zhang X; Li Y; Tian M; Liu Y; Zhao Y; Li C Int J Tuberc Lung Dis; 2010 Nov; 14(11):1436-41, i. PubMed ID: 20937184 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of the GenoType® MTBDRplus assay and identification of a rare mutation for improving MDR-TB detection. Jin J; Zhang Y; Fan X; Diao N; Shao L; Wang F; Hu P; Wang S; Weng X; Zhang W Int J Tuberc Lung Dis; 2012 Apr; 16(4):521-6. PubMed ID: 22325117 [TBL] [Abstract][Full Text] [Related]
32. Novel diagnostics and therapeutics for drug-resistant tuberculosis. Toosky M; Javid B Br Med Bull; 2014 Jun; 110(1):129-40. PubMed ID: 24810849 [TBL] [Abstract][Full Text] [Related]
33. [Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis]. Gui XH; Xu P; Zhao M; Wang LL; Wu J; Li J; Gao Q; Mei J Zhonghua Jie He He Hu Xi Za Zhi; 2010 Jan; 33(1):43-5. PubMed ID: 20368024 [TBL] [Abstract][Full Text] [Related]
34. Tuberculosis drug resistance testing by molecular methods: opportunities and challenges in resource limited settings. Abebe G; Paasch F; Apers L; Rigouts L; Colebunders R J Microbiol Methods; 2011 Feb; 84(2):155-60. PubMed ID: 21129417 [TBL] [Abstract][Full Text] [Related]
35. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance. Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897 [TBL] [Abstract][Full Text] [Related]
36. Second-line drug susceptibilities of multidrug-resistant tuberculosis strains isolated in Thailand: an update. Chaiprasert A; Srimuang S; Tingtoy N; Makhao N; Sirirudeeporn P; Tomnongdee N; Theankeaw O; Charoensook S; Leechawengwongs M; Prammananan T Int J Tuberc Lung Dis; 2014 Aug; 18(8):961-3. PubMed ID: 25199012 [TBL] [Abstract][Full Text] [Related]
37. Early detection of multi-drug resistance and common mutations in Mycobacterium tuberculosis isolates from Delhi using GenoType MTBDRplus assay. Singhal R; Myneedu VP; Arora J; Singh N; Bhalla M; Verma A; Sarin R Indian J Med Microbiol; 2015 Feb; 33 Suppl():46-52. PubMed ID: 25657156 [TBL] [Abstract][Full Text] [Related]
38. In vitro synergistic activity of clofazimine and other antituberculous drugs against multidrug-resistant Mycobacterium tuberculosis isolates. Zhang Z; Li T; Qu G; Pang Y; Zhao Y Int J Antimicrob Agents; 2015 Jan; 45(1):71-5. PubMed ID: 25459737 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of a rapid screening test for rifampicin resistance in re-treatment tuberculosis patients in the Eastern Cape. Albert H; Trollip AP; Seaman T; Abrahams C; Mole RJ; Jordaan A; Victor T; Hoosain E S Afr Med J; 2007 Sep; 97(9):858-63. PubMed ID: 17985057 [TBL] [Abstract][Full Text] [Related]